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Research Article
Synthesis of the chiral selector heptakis
(6-O-methyl)--cyclodextrin by phase-
transfer catalysis and hydrazine-mediated
transfer-hydrogenation
The exhaustive primary-side alkylation of cyclodextrins has never been achieved directly.
The undesired and simultaneous derivatization of the secondary hydroxyl moieties gener-
ates intricate isomericmixtures that are challenging to purify, analyse and characterize. The
aim of this study was to develop a chromatography-free and up-scalable strategy towards
the preparation of per-6-O-methylated cyclodextrin and to test the compound as potential
chiral selector. The target molecule was prepared according to a five-step synthesis by us-
ing methyltriphenylphosphonium bromide as catalyst under heterogeneous conditions.
The removal of benzyl moieties, used as temporary secondary-side protecting groups, was
attained by applying hydrazine-carbonate in the presence of Pd/C. All the intermediates
were obtained in high yields, thoroughly characterized and their purity was assessed by
ad-hoc developed HPLCmethods. The per-6-O-methylated -cyclodextrin showed promis-
ing chiral recognition ability as background electrolyte additive in cyclodextrin-modified
capillary electrophoresis using the recreational drug methylene-dioxypyrovalerone as
model compound. Additionally, a model for the inclusion geometry between the single
isomer host and the selected drug was developed based on the extensive 2D NMR analysis.
The versatility of the proposed synthetic strategy opens the way to the industrial production
of homogeneously primary-alkylated cyclodextrins and to their wide application in chiral
separation of various drugs.
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 Additional supporting information may be found online in the Supporting Infor-mation section at the end of the article.
1 Introduction
Cyclodextrins (CDs) are water-soluble cyclic oligosaccharides
presenting a truncated-cone shape limiting a hydrophobic
cavity. These sugars have been extensively utilized as
excipients in pharmaceutical and food industry [1] and due
to their specific 3D arrangement they have been used as an-
alytical tools for enantioseparation [2], proposed as artificial
enzyme [3] and applied as catalyst for organic reactions [4].
Particularly, CDs have been exploited as mass transfer addi-
tives for decades [5] and their role as inverse phase transfer
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catalyst has been widely investigated [6]. However, the deriva-
tization of CDs based on phase transfer catalysis (PTC) is a
field poorly investigated and only a few works deal with this
topic. Szejtli et al. [7] investigated methylation of unmodified
CDs with dimethylsulfate under PTC conditions. In their
optimization work the influence of solvent, catalyst and base
has been explored. In the general reaction procedure, native
CDs and the selected base were suspended in a poorly soluble
solvent and the methylating agent was added subsequently.
According to theHungarian team, THFwas the best perform-
ing solvent, KOH powder the optimal base and Aliquat R© the
most efficient catalyst. To the best of our knowledge, no other
study has been reported on the modification of CDs under
PTC. However, Ciucanu and Kerek previously reported an in-
depth study about permethylation of sugars in dipolar aprotic
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solvents with methyl-iodide and solid base such as NaOH,
KOH or tert-BuOH/NaOH [8]. Their investigation showed
that the combination of methyl iodide, solid alkali-metal
hydroxide and dimethylsulfoxide is a rapid and high-yielding
method for the complete methylation of carbohydrates.
The selective modification of CDs is an evergreen chal-
lenge for synthetic chemist. For example, direct per-6-O-
alkylation has not been accomplished yet. The primary-side
homogeneous substitution of CDs can be only obtained
through “the long method” where the primary face is first
protected and the secondary side is temporary blocked. The
primary face is then deprotected and reacted with alkyl halide
and the protecting groups on the secondary side are finally
removed. The most common and effective way of protecting
the primary face of the CDs is based on tert-butyldimethylsilyl
chloride (TBDMS-Cl). Two main procedures are available
for the exhaustive per-6-silylation of CDs: the approach in-
troduced by Takeo [9] that utilizes DMF-imidazole as envi-
ronment for the tert-butyldimethylsilylation and the method
based on pyridine [10]. Regardless of the upgrades introduced
by other groups to the twomain silylating procedures [11,12],
improvements are needed concerning the simplicity of equip-
ment and scale-up, easiness of work-up and purification.
Additionally, the removal of secondary side protecting
groups such as benzyl moieties from CD scaffolds is usually
carried out by hydrogenolysis over metals, palladium deriva-
tives most commonly [13, 14]. However, hydrogenolysis has
one main drawback, particularly on the large scale that is
the danger and inconvenience of handling highly flammable
hydrogen gas in high pressure explosion-proof vessel. The
strict requirements needed for the equipment make this ap-
proach not economically advantageous.
On the contrary, catalytic transfer hydrogenation,
using in-situ hydrogen production, has emerged as an appeal-
able alternative solution during the last century. Hydrazine-
carbonate with its inherent advantages such as stability, con-
venience of use, cost effectiveness and ease of availability, is a
practical source of hydrogen. The combination of hydrazine
carbonate with transition metal catalyst such as palladium
generates a mild and efficient catalytic transfer hydrogena-
tion system conveniently used in industrial scale. The use of
hydrazine-mediated transfer-hydrogenation for the debenzy-
lation of CDs has never been reported before. Originally, this
method was introduced by Jicsinszky [15] for the effective re-
duction of primary-substituted azidoCD to amino derivatives.
The synthesis of the single isomer, heptakis(6-O-methyl)-
-CD (6-Me--CD), has been only described in the pioneer-
ing work of Takeo et al. [16] and in the sophisticated work of
Uccello-Barretta et al. [17]. The first procedure, based on ex-
tensive chromatographic purification, resulted in low yields
for each compound, while the use of hazardous reagents
in the second approach makes challenging the industrial
scale-up.
In this work, we developed and proposed an alternative
and efficient synthesis for heptakis(6-O-methyl)--CD (and in
general for 6-O-alkylated CDs), amenable of industrial scale-
up and completely chromatography-free at each step. The
current procedure allowed the 100–500 g scale preparation of
each intermediate and resulted in 50 g batch production of
the final compound. The single isomer methylated CD has
been additionally investigated as chiral selector toward the
psychoactive drug methylenedioxypyrovalerone (MDPV).
2 Materials and methods
The -cyclodextrin was the product of Wacker Chemie AG
(Mu¨nchen, Germany); syntheses solvents such as pyridine
(Pyr), tetrahydrofuran (THF) and ethanol (EtOH, 96%) were
of reagent grade and were sourced from Molar Chemi-
cals (Hala´sztelek, Hungary); methyltriphenylphosphonium
bromide (98%), benzyl bromide (Bn-Br, 98%), tetrabutyl-
ammonium fluoride (TBAF, 98%), palladium on activated
charcoal (10%), potassium hydroxide (KOH, 85%), tert-
butyldimethylsilyl chloride (TBDMSCl, 97%), methyl iodide
(ReagentPlus R©, 99%), hydrazine carbonate (70% in water,
ca. 7.3 M), D2O (99.9% D atom), DMSO-d6 (99.9 atom %
D) and CDCl3 (99.8 atom % D) were sourced from Sigma
Aldrich (St. Louis, MO, USA). Silica gel coated aluminum
sheets were from Merck. Acetonitrile (HiPerSolv for HPLC-
SuperGradient) was the product of VWR International (Rad-
nor, PA, USA).Methanol (MeOH), ethyl acetate (EtOAc), hex-
ane, chloroform (CHCl3), 1-propanol, triethylamine, formic
acid, 1,4-dioxane, ethanol (96%), H2SO4 (96%), ammonia
(25%) used for preparation of HPLC and TLC solutions, as
well as H3PO4 (85%), NaOH, KH2PO4 anhydrous and DCl
(99% D atom) used for the preparation of CE and NMR
buffer solutions were of analytical grade and purchased from
Molar Chemicals (Hala´sztelek, Hungary) . All reagents were
used without further purification. Purified water (Millipore-
Synergy) was used throughout the capillary electrophoretic
study. The chiral test analytes used in this study were ob-
tained from commercial suppliers.
TLCwas performed on silica gel coated aluminum sheets
DC-Alufolien Keiselgel 60 F254 (Merck, Germany). Plates
were developed in a saturated chamber in a EtOAc:EtOH
(96%):H2O = 30:5:4 (intermediate I), Hexane:EtOAc = 9:1
(intermediate II), CHCl3:MeOH= 9:1 (intemediate III), chlo-
roform containing 0.5-1.0% ethanol (intermediate IV) or 1,4-
dioxane:ammonia (25%):1-propanol = 10:7:3 (6-Me--CD).
Visualization of the CD derivatives was achieved under UV
light at 254 nm and by dipping the TLC plates in 50%H2SO4-
ethanol solution and subsequent carbonization using a heat
gun. Quantitative analysis of TLC plates was performed with
the software JustQuantify Free.
Melting points were measured on a Bu¨chi B-21 450melt-
ing point apparatus and are uncorrected. Optical rotations
were recorded on a Jasco P-1030 22 polarimeter at room tem-
perature. []D values are given in 10−1 deg/cm/g. MALDI-
TOF mass spectra were recorded on a 4800 Plus AB SCIEX
spectrometer with 2,5-dihydroxybenzoic acid (DHB) as the
matrix. Infrared spectra were recorded as KBr disk on a
Perkin Elmer FTIR spectrometer SpectrumRX1. HPLCmea-
surements were performed on anAgilent 1260 InfinityHPLC
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system equippedwithUVdetector (Agilent 1200 SeriesDiode
Array Detector, G1315B) coupled to refractive index (RI) de-
tector (Agilent 1260 Infinity Refractive Index Detector+ 8 L
flowcell, G1362A) or with UV detector coupled to evapora-
tive light scattering (ELS) detector (Agilent 385 Evaporative
Light Scattering Detector, G4261A). These setups were used
to determine the purity of all cyclodextrin derivatives.
HPLC method 1 Purity assessment of intermediate 1 (6-
TBDMS--CD) was obtained on a Luna C18 250 × 4.6 mm,
5 m (Phenomenex, Torrance, CA, USA) analytical column
with the mobile phase of methanol:ethylacetate (78:22), iso-
cratic elution at a flow rate of 1.8 mL/min and RI detection.
HPLC method 2 Purity assessment of intermediate 2 (6-
TBDMS-2,3-Bn--CD) was obtained on a Luna C18 250 ×
4.6 mm, 5 m analytical column with the mobile phase
of (methanol:acetonitrile (9:1): ethyl acetate (80:20), isocratic
elution at a flow rate of 1.8 mL/min and ELS detection.
HPLC method 3 Purity assessment of intermediate 3
(2,3-Bn--CD) was obtained on a Kinetex C18 100 × 4.6 mm,
2.6m (Phenomenex, Torrance, CA, USA) analytical column
with a gradient elution of methanol:water at a flow rate of 1
mL/min and DAD detection at 254 nm.
HPLC method 4 Purity assessment of intermediate 4
(6-Me-2,3-Bn--CD) was obtained on a Luna C18 250 ×
4.6 mm, 5 m analytical column with the mobile phase of
(methanol:acetonitrile (9:1):ethyl acetate (40:60), isocratic elu-
tion at a flow rate of 1.8 mL/min and ELS detection.
HPLC method 5 Purity assessment of compound 5 (6-
Me--CD) was obtained on a Kinetex C18 100 × 4.6 mm,
2.6 m analytical column with a gradient elution of
methanol:water at a flow rate of 0.7 mL/min and ELS
detection.
CE measurements were carried out on an Agilent 7100
instrument (Agilent Technologies, Waldbronn, Germany),
equipped with a DAD and the Chemstation software for data
handling. Measurements were performed in untreated fused
silica capillaries (33.5 cm total and 25 cm effective length
and 50 m id) purchased from Agilent Technologies. Prior
to all runs the capillary was preconditioned by rinsing with
0.1 M NaOH (2 min), water (2 min) and the appropriate BGE
(3 min). The temperature of the capillary was set to 20°C.
During measurements 20 kV was applied, UV detection was
performed at 200 nm. Samples were injected hydrodynami-
cally (40 mbar x 3 s). The running buffer was 20 mM phos-
phoric acid (85%) adjusted to pH 2.5 with 1 M NaOH. The
BGE contained 6-Me--CD at 1 mM and 2.5 mM concen-
trations. Stock solution of MDPV (1 mg/mL) was prepared
in methanol and its 50-fold dilution with water was used to
prepare working solutions for CE analysis.
NMR experiments were carried out on a 600 MHz
Varian DDR NMR spectrometer equipped with a 5 mm
inverse-detection gradient (IDPFG) probehead. Standard
pulse sequences and processing routines available in VnmrJ
3.2 C/Chempack 5.1 were used for structure identifications.
The complete resonance assignments were established from
direct 1H–13C, long-range 1H–13C, and scalar spin–spin
connectivities derived from 1D 1H, 13C, 1D TOCSY, 1H–1H
gCOSY, zTOCSY, 1H–13C gHSQCAD, 1H–13C gHMBCAD
experiments, respectively. The probe temperature was main-
tained at 298 K and standard 5 mm NMR tubes were used.
The 1H chemical shifts were referenced to the applied NMR
solvent (CDCl3 (1H ref . = 7.24 ppm, 13C ref . = 77.23 ppm),
DMSO-d6 (1H ref . = 2.50 ppm, 13C ref . = 39.52 ppm) or D2O
(1H ref . = 4.79 ppm)).
2.1 Synthesis
2.1.1 Heptakis(6-O-tert-butyldimethylsilyl)--cyclo-
dextrin (6-TBDMS--CD, Intermediate 1)
Dry -cyclodextrin (312.5 g, 0.27 mol) was solubilized
in dry pyridine (5 L) under inert atmosphere and tert-
butyldimethylsilyl-chloride (347.5 g, 2.31 mol) was added
portionwise. The resulting suspension was stirred at room
temperature for 6 h. The reaction was monitored by TLC
(EtOAc:EtOH (96%):H2O = 30:5:4), showing three spots at
Rf = 0.7, 0.6 and 0.3. Portions of TBDMSCl (41.5 g, 0.27 mol)
were added every 6 h until the spot withRf = 0.3 disappeared.
The mixture was gradually poured into water (30 L) under
vigorous stirring and the obtained white precipitate was fil-
tered (sintered glass filter porosity G3). The solid was washed
with water (5 × 3 L) and dried into a vacuum drying box.
The crude product ( 560 g) was solubilized in DMF (1.5 L)
acetone (375 mL) mixture, hot filtered and precipitated with
water (9.3 L). The white solid was filtered and washed with
water (3 × 3 L). The precipitation procedure based on DMF-
acetone-water was repeated twice until the spot with Rf = 0.7
disappeared. The white solid was dried until constant weight
at 50°C into a vacuum drying box (437 g, 0.23 mol, 82%).
The purity of the compoundwas estimated98.5%based
on HPLC method 1.
m.p. 296–300°C (decomp.), lit. values 299–318°C [1-3];
[D25] = +113.22° (c = 1, CH2Cl2), lit. values +(105.7-
115.0)°C [2-4]; Rf = 0.6 (EtOAc:EtOH (96%):H2O = 30:5:4);
IR /cm−1 3392, 2954, 2930, 1253, 1156, 1085, 835,
778.1H NMR (600 MHz, CDCl3, 298 K) (ppm) 4.87 (d, J =
3.5 Hz, 7H, H1), 4.02 (t, J = 9.2 Hz, 7H, H3), 3.88 (dd, J =
11.4 Hz, 3.1 Hz, 7H, H6a), 3.69 (d, J = 10.6 Hz, 7H, H6b),
3.62 (dd, J = 9.7, 3.4 Hz, 7H, H2), 3.60 (m, 7H, H5), 3.54
(t, J = 9.3 Hz 7H, H4), 0.85 (s, 63H, H8), 0.02 (s, 21H,
H7), 0.01 (s, 21H, H7’); 13C NMR (151 MHz, CDCl3, 298
K) (ppm) 102.24 (C1), 82.01 (C4), 73.84 (C2), 73.63 (C3),
72.78 (C5), 61.86 (C6), 26.13, (C8), 18.50 (C9), -4.84 (C7’),
-4.96 (C7). MALDI-TOF m/z [M + Na]+, found: 1957.799,
calculated for C84H168O35Si7Na: 1957.799.
2.1.2 Heptakis(6-O-tert-butyldimethylsilyl-2,3-di-O-
benzyl)--cyclodextrin (6-TBDMS-2,3-Bn--CD,
Intermediate 2)
Heptakis(6-O-tert-butyldimethylsilyl)--cyclodextrin (487.6 g,
0.25 mol) was dissolved in THF (5 L). The solution was
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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cooled-downwith an ice-water bath to 10°CandKOH(1.29 kg,
23 mol) was added portionwise under vigorous stirring. The
obtained white suspension at first slightly gelified then be-
came more stirrable. Methyltriphenylphosphonium bromide
(50.4 g, 0.14 mol) was added to the reaction mixture and the
white suspension was stirred for 3 h. Benzyl bromide (460.8
mL, 662.6 g, 3.87 mol) was slowly and carefully added to the
heterogeneous mixture (2 h addition), by keeping the tem-
perature always below 25°C. After 1 h stirring the reaction
mixture became of a pearly white colour showing a milk-like
consistence. The reaction was stirred at room temperature
overnight. The proceeding of the reaction was monitored by
TLC (Hexane:EtOAc = 9:1), the reaction mixture was cooled-
down to 10°Cand a second portion of KOH (129.6 g, 2.31mol)
and BnBr (46.1 mL, 66.30 g, 0.39 mol) was added. After 2 h, a
third portion of KOH (64.8 g, 1.15mol) and BnBr (23mL, 33.1
g, 0.19mol) was added and the reactionmixture was addition-
ally stirred for 3 h. The heterogeneousmixture was filtered on
a sintered glass filter (porosity 4) and the solid was thoroughly
washed with THF (3× 1.8 L). The filtrate was concentrated at
rotavapor ( 180 mL) and poured to MeOH (7.2 L) under vig-
orous stirring. The resulting yellowish, gel-like material was
separated by decantation. The solid was extensively washed
withH2O (5× 9 L) andwithMeOH:H2O= 1:9 (3× 3.6 L) and
finally dried until constant weight in a vacuum drying box in
the presence of P2O5 and KOH as desiccants (753 g, 0.24mol,
93%).
The purity of the compoundwas estimated98.3%based
on HPLC method 2.
m.p. 87–90°C; [D25] = +42.39° (c = 1, CH2Cl2); Rf =
0.55 (Hexane:EtOAc = 9:1); IR /cm−1 2954, 2928, 2856,
1252, 1143, 1094, 1034, 834, 696. 1H NMR (600MHz, CDCl3,
298 K) (ppm) 7.19-7.00 (m, 70H, Ph), 5.30 (br d, J = 2.3 Hz,
7H, H1), 5.06 (d, J = 10.6 Hz, 7H, O3CH2Ph), 4.69 (d, J =
10.6 Hz, 7H, O3CH2Ph), 4.49 (qd, J = 12.2, 3.8 Hz, 14H,
O2CH2Ph), 4.24 (d, J = 11.1 Hz, 7H, H6a), 4.04 (t, J = 9.2
Hz, 7H, H3), 3.99 (t, J = 9.1 Hz, 7H, H4), 3.72 (br d, J =
9.2 Hz, 7H, H5), 3.69 (d, J = 11.4 Hz, 7H, H6b), 3.37 (dd,
J = 9.6, 3.4 Hz, 7H, H2), 0.86 (br s, 63H, H8), 0.01 (br s,
21H, H7), 0.00 (br s, 21H, H7’); 13C NMR (151 MHz, CDCl3,
298 K) (ppm) 139.50 (quaternary 3OBn, 1C), 138.49 (qua-
ternary 2OBn, 1C), 127.86 (2OBn, 2C), 127.68 (3OBn, 2C),
128.21 (OBn, 3C), 128.05 (OBn, 3C), 127.43 (OBn, 4C), 126.98
(OBn, 4C), 98.09 (C1), 81.05 (C3), 79.43 (C2), 77.86 (C4), 75.64
(O3CH2Ph), 72.73 (O2CH2Ph), 72.67 (C5), 62.54, (C6), 26.12
(C8), 18.49 (C9), -4.63 (C7’), -4.99 (C7). MALDI-TOF m/z [M
+ Na]+, found: 3218.530, calculated for C182H252O35Si7Na:
3219.515.
2.1.3 Heptakis(2,3-di-O-benzyl)--cyclodextrin
(2,3-Bn--CD, Intermediate 3)
Heptakis(6-O-tert-butyldimethylsilyl-2,3-di-O-benzyl)--
cyclodextrin (125 g, 39.1 mmol) was solubilized in THF (5 L)
under inert atmosphere and tetrabutylammonium fluoride
trihydrate (197.5 g, 0.62 mol) was added portionwise. The
yellowish solution was stirred overnight at room tempera-
ture. The desilylation was followed by TLC (CHCl3:MeOH
= 9:1) and it was completed overnight. The reaction crude
was concentrated at rotavapor, methanol was added (1.2 L)
and the solution was once more concentrated at rotavapor.
The azeotropic distillation procedure was repetead three
times (3 × 1.2 L methanol) and the crude was finally
concentrated until dryness. The residual yellowish material
was suspended in water (2.4 L), filtered on a sintered glass
filter (porosity 4) and extensively washed with water (5 ×
6.2 L) and with a mixture of MeOH:H2O = 1:9 (3 × 2.5 mL)
until a white, odourless, solid was obtained. The white solid
was dried until constant weight into a vacuum drying box in
the presence of P2O5 and KOH as desiccants (86 g, 36 mmol,
92%).
The purity of the compoundwas estimated98.3%based
on HPLC method 3.
m.p. 159–161°C, lit. values 163–164°C [5]; [D25] =
+52.89° (c = 1, CH2Cl2); Rf = 0.16 (CHCl3:MeOH =
9:1) as final, purified compound while during the reaction
monitoring the Rf is higher due to the presence of tetra-
butylammonium fluoride (Rf = 0.42). IR /cm−1 3356, 2927,
1497, 1454, 1161, 1099, 1027, 733, 696.1H NMR (600 MHz,
DMSO-d6, 298 K) (ppm) 7.22-7.06 (m, 70H, Ph), 5.27
(br d, J = 3.2 Hz, 7H, H1), 4.92 (d, J = 11.5 Hz, 7H,
O3CHaHPh), 4.63 (br m, 14H, O3CHHbPh/(C6)H2-OH),
4.52 (dd, J = 12.6 Hz, 14H, O2CH2Ph), 3.91 (t, J = 8.6 Hz,
7H, H3), 3.86 (m, 7H, H6a), 3.83 (m, 7H, H4), 3.78 (m, 7H,
H5), 3.66 (br d, J = 11.1 Hz, 7H, H6b), 3.41 (overlapped with
HOD signal, 7H, H2); 13C NMR (151 MHz, DMSO-d6, 298
K) (ppm) 139.01 (quaternary Ph, 1C), 138.38 (quaternary Ph,
1C) 128.00 (Ph, 3C), 127.88 (Ph, 3C), 127.36 (Ph, 2C), 127.28
(Ph, 4C), 127.17 (Ph, 2C), 127.03 (Ph, 4C), 96.65 (C1), 80.49
(C3), 78.66 (C2), 77.12 (C4), 74.52 (O3CH2Ph), 72.21 (C5),
71.60 (O2CH2Ph), 60.19 (C6). MALDI-TOF m/z [M + Na]+,
found: 2419.090, calculated for C140H154O35Na: 2419.688.
2.1.4 Heptakis(6-O-methyl-2,3-di-O-benzyl)--cyclo-
dextrin (6-Me-2,3-Bn--CD, Intermediate 4)
Heptakis(2,3-di-O-benzyl)--cyclodextrin (350 g, 0.15 mol)
was solubilized in THF (5 L). The slightly greenish solution
was cooled-down with an ice-water bath to 10°C and KOH
(390 g, 6.95 mol) was added portionwise under vigorous
stirring. Methyltriphenylphosphonium bromide (24.5 g,
68.6 mmol) was added to the slightly greenish suspension
and the reaction mixture was stirred for 1 h. Methyl iodide
(87.5 mL, 199.5 g, 1.4 mol) was slowly and carefully added
to the heterogeneous mixture (30 min addition) by keeping
the temperature below 25°C. After 1 h stirring the reaction
mixture became of a pearly white colour and it showed
a milk-like consistence. The reaction was stirred at room
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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Figure 1. Synthesis of heptakis(6-O-methyl)--CD (compound 5) with reagents, conditions and yields.
temperature overnight. The proceeding of the reaction was
monitored by TLC (chloroform containing 0.5–1% ethanol
as stabilizer was used as eluent). The reaction mixture was
filtered on a sintered glass filter (porosity 4) and the solid was
thoroughly washed with THF (3 × 1.75 L). The filtrate was
concentrated at rotavapor ( 180 mL) and poured to MeOH
(1.8 L) under vigorous stirring. The resulting yellowish,
gel-like material was separated by decantation, resuspended
in water (3.5 L), filtered and extensively washed with H2O
(5 × 1.8 mL) and with a mixture MeOH:H2O = 1:9 (3 ×
1.8 mL) until a white solid was obtained. The white solid was
dried until constant weight in a vacuum drying box in the
presence of P2O5 and KOH as desiccants (346 g, 0.14 mmol,
95%).
The purity of the compoundwas estimated98.6%based
on HPLC method 4.
m.p. 88–89°C; [D25] = +3.25° (c = 1, CH2Cl2); Rf =
0.25 (chloroform). IR /cm−1 2925, 2891, 1497, 1454, 1356,
1197, 1139, 1094, 1040, 734, 696. 1HNMR (600MHz, DMSO-
d6, 298 K) (ppm) 7.24-7.08 (m, 70H, Ph), 5.09 (br d, J =
1.8 Hz, 7H, H1), 4.93 (d, J = 11.1 Hz, 7H, O3CHaHPh),
4.61 (d, J = 11.1 Hz, 7H, O3CHHbPh), 4.56 (d, J =
12.3 Hz, 7H, O2CHaHPh), 4.47 (d, J = 12.3 Hz, 7H,
O2CHHbPh), 3.88 (m, 7H, H3), 3.87 (m, 7H, H5), 3.81
(dd, J = 11.2, 4.4 Hz, 7H, H6a), 3.71 (br t, J = 8.7 Hz, 7H,
H4), 3.50 (d, J = 10.5 Hz, 7H, H6b), 3.44 (dd, J = 9.5, 3.3
Hz, 7H, H2), 3.23 (s, 21H, OCH3). 13C NMR (151 MHz,
DMSO-d6, 298 K) (ppm) 138.90 (quaternary 3OBn, 1C),
138.33 (quaternary 2OBn, 1C), 127.93 (2OBn, 3C), 127.82
(3OBn, 3C), 127.45 (2OBn, 2C), 127.25 (2OBn, 4C), 127.11
(3OBn, 2C), 126.96 (3OBn, 4C), 97.20 (C1), 80.24 (C3),
78.54 (C2), 77.86 (C4), 74.46 (O3CH2Ph), 71.82 (O2CH2Ph),
71.09 (C6), 70.69 (C5), 58.19, (OCH3). MALDI-TOF m/z
[M + Na]+, found: 2517.934, calculated for C147H168O35Na:
2517.875.
2.1.5 Heptakis(6-O-methyl)--cyclodextrin
(6-Me--CD, compound 5)
Heptakis(6-O-methyl-2,3-di-O-benzyl)--cyclodextrin (125 g,
50 mmol) was solubilized in methanol (5 L). The reaction
mixture was heated at 40°C, Pd/C (31.3 g) was added under
vigorous stirring and hydrazine carbonate (1.2 L) was added
dropwise to the vessel (3 h addition). The mixture was heated
at gentle reflux for 3 h and the proceeding of the reaction
was monitored by TLC (1,4-dioxane:NH3 (25%):1-propanol
= 10:7:3). The reaction mixture was cooled-down to room
temperature, filtered on a sintered glass filter (porosity 3) and
the Pd/C pad was thoroughly washed with MeOH (3 × 6.5
L), H2O (3 × 6.5 L) and MeOH:H2O = 50:50 (3 × 6.5 L).
The filtrate was evaporated until dryness at rotavapor (60°C).
The residual solid was solubilized in water (12.5 L), treated
with ion exchange resins and clarified with charcoal. The
obtained solution was then filtered through a pad of celite
andfinally evaporated until dryness. Thewhite solidwas dried
until constant weight in a vacuum drying box in the presence
of P2O5 and KOH as desiccating agents (52.5 g, 42.6 mmol,
86%).
The purity of the compoundwas estimated98.2%based
on HPLC method 5.
m.p. 299–303°C (decomp.), lit. values 303–310°C [6];
[D25] = +164.24° (c = 1, H2O), lit. value +166°C [1]; Rf
= 0.6 (1,4-dioxane:NH3 (25%):1-propanol = 10:7:3 (v/v/v)).
IR /cm−1 3379, 2931, 1156, 1087, 1041. 1H NMR (600 MHz,
D2O, 298 K) (ppm) 5.06 (d, J = 3.7 Hz, 7H, H1), 3.97 (t, J =
9.6 Hz, 7H, H3), 3.98 (dd, J = 10.0, 2.9 Hz, 7H, H5), 3.77 (m,
14H, H6), 3.65 (dd, J = 9.9, 3.6 Hz, 7H, H2), 3.60 (t, J = 9.5
Hz, 7H, H4), 3.42 (s, 21H, OCH3).13C NMR (151 MHz, D2O,
298 K) (ppm) 104.44 (C1), 83.84 (C4), 75.60 (C3), 74.61 (C2),
73.21 (C6), 73.02 (C5), 60.99, (OCH3).MALDI-TOFm/z [M+
Na]+, found: 1255.925, calculated for C49H84O35Na: 1256.159.
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. 3 Results and discussion
3.1 Synthesis and characterization
The primary hydroxyl groups of the native -CD were se-
lectively protected with TBDMS-Cl in pyridine. The use of
pyridine instead of the combination of DMF-imidazole pro-
posed by Takeomade the reaction crude composition simpler
(three components versus four components) and cost-effective
(exclusion of imidazole). In order to obtain a crude which
can be purified by sole crystallization, the reaction conditions
were tuned towards a mixture made from intermediate 1 (see
Fig. 1) and a discrete amount of over-silylated CDs (see Sup-
porting Information Fig. 1).
These latter CD-related impurities are more soluble in
DMF-acetone mixture than the symmetric per 6-substituted
silyl--CD derivative and could be effectively removed by
precipitation of the intermediate 1. The crystallization cycles
were repeated until the purity was optimal (98%, with two
crystallization cycles). The second step, the benzylation by
PTC, was the key point of the whole procedure. In Takeo’s
approach, the secondary side’s temporary protection was
achieved under relative harsh conditions (acetic anhydride
in pyridine at 100°C) and the product was isolated by chro-
matography. On the contrary, the heterogeneous catalytic
set-up allowed exhaustive protection of the secondary rim
under mild conditions, without the need of rigorous dry
environment and generated a reaction crude that was puri-
fied by simple precipitation with excellent yields. It is worth
to mention that reported methods for partially or complete
benzylation of CDs require strict anhydrous conditions [18],
are based on sodium hydride [13, 19–21] and usually need
chromatography for isolation of the products [9]. The scale-up
based on sodium hydride is precarious, it needs explosion-
proof reactors and it is not economically advantageous.
Additionally, the chromatography needed for purification
is time-consuming, challenging and expensive. Contrary to
that, the method developed herein uses a readily up-scalable
benzylation/alkylation based on an easily accessible organic
phosphonium salt as catalyst. Among the tested catalysts
(see Supporting Information Table 1) triphenylmethyl
phosphonium bromide was uniquely effective in promot-
ing fully secondary-side substitution with a large variety of
alkylating agents (such asmethyl-iodide, ethyl-iodide, benzyl-
bromide/chloride and allyl bromide) and independently
from the anion utilized. Furthermore, this molecule and its
by-products are highly water soluble and hence promptly
and effectively removed by precipitation. It should be also
emphasized that under PTC conditions, the reaction rate
and the exothermicity intimately connected to the alkylation
process, are simply controlled by adjusting the stirring speed
without extra cooling; this is particularly advantageous when
large reaction batches are handled. In the eventuality that
2,3-di-O-alkylation of the primary-side protected CD did not
occur exhaustively, with the current method, the reaction can
be pushed to completeness by extra additions of calculated
amount of base (KOH) and/or alkyl halide. On the contrary,
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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Figure 3. The 1H NMR spectrum of racemic MDPV (blue colour, top) and the 1H NMR spectrum of racemic MDPV:6-Me--CD solution at
1:1.5 molar ratio (brown, bottom). The latter shows remarkable enantioresolution effects as indicated by*.
alkylation reactions based on hydrides need to be reprocessed
for yielding a homogeneous product as successive additions
of reactants are ineffective for achieving a full conversion. The
minimal work-up for the PTC-based benzylation consisted
of KOH filtration (KOH is acting as a base as well as a drying
agent), azeotropic distillation and precipitation. All these
advantageous featuresmake PTC ideal for industrial scale-up.
According to our experience, deprotection of the primary-
side (O-desilylation) can be exhaustively accomplished with
excess of (harmless) TBAF, at room temperature, overnight in
THF,while, under the same conditions, the deprotection is in-
complete in MeOH. The secondary-side benzylated interme-
diate was recovered in high purity by washing out the excess
of TBAF with methanol:water mixtures. This method is sim-
pler and safer than Takeo’s approach, where O-desilylation
was performed in DCM with (hazardous) boron trifluoride
etherate and heptakis(2,3-di-O-acetyl)--CD was isolated by
chromatography.
In the present strategy, per-6-O-methylation of the CD
ring was also achieved by PTC with methyl iodide. This step
clearly shows that the developed procedure is versatile, from
every point of view. It has been reported that alkyl-iodide
agents are poisonous for bromide-based catalysts, while in
the explored conditions, the phosphonium salt did not show
any limitation regarding the choice of the halogen counter-
part (see Supporting Information Table 1). The methylation
resulted in a crude which was easily purified by filtration,
azeotropic distillation and precipitation resulting heptakis
(6-O-methyl)--CD in good yield. Methylation with methyl
trifluoromethanesulfonate (triflate) and DCM in sealed
tube in the presence of 2,6-di-tert-butyl-4-methypyridine
as catalyst and chromatographic purification afforded
heptakis(2,3-di-O-acetyl)--CD in the work of Takeo.
The current debenzylation procedure requires 25% w/w
palladium content and a gentle reflux to achieve exhaustive
deprotection. The hydrogen gas evolution caused by the
addition of hydrazine carbonate to the heterogeneous mix-
ture is effectively controlled by slowly adding the hydrogen
source. Heptakis(6-O-methyl)--CD is isolated by removing
the transition metal on a celite pad and by treating the
resulting filtrate with ion exchange resins and charcoal.
In the procedure of Takeo [15] the primary-substituted
methylated -CD was obtained by Zemple´n O-deacetylation,
a very effective deprotection method. This is the only step of
the all synthetic strategy proposed by the Japanese group that
is chromatography-free. Globally, a chromatography-free
synthetic strategy towards heptakis(6-O-methyl)--CD has
been developed. The synthetic approach could be potentially
extended to the alpha and gamma analogues and used as pro-
tocol for the industrial preparation of any per(6-O-alkyl)-CD.
All the compounds have been extensively and unam-
biguously characterized by NMR, MALDI-MS and IR. Op-
tical rotations and melting points have been measured as
well. The purity of all the derivatives have been estab-
lished by ad-hoc developed HPLC methods (see Supporting
Information).
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Figure 4. Partial 2D ROESY NMR spectrum of MDPV and 6-Me--CD showing intense cross-peaks between the inner CD protons (H3, H5)
and MDPV.
3.2 CE separation of racemic MVPD using
6-Me--CD as chiral selector
Chiral CE mediated by CDs is continuously flourishing, as
it still offers efficient separations at a reasonable costs and
it is completely suited for the rapid screening of optimal
conditions in an environmentally friendly fashion. Recent
trends reflect that CDs with well-defined structures (“single
isomer CDs”) are preferred as background electrolyte addi-
tives in order to overcome batch-to-batch reproducibility is-
sues as a result of poorly characterized structures of isomeric
mixtures. Additionally, it has been reported that exhaustive
substitution (methylation in particular) at the primary posi-
tions significantly improves the binding potential of cyclodex-
trin derivatives [22]. The applicability of 6-Me--CD as chiral
selector was tested in CD-modified capillary electrophoresis
using the racemic MDPV as a model compound. The syn-
thetic cathinone, 3,4-MDPV is a popular and at the same
time dangerous recreational drug. Despite its similar struc-
ture to methamphetamine, MDPV acts by potent inhibition
of dopamine reuptake rather than inducing dopamine re-
lease like methamphetamine. While this drug is only avail-
able as a racemic mixture so far, its (S)-enantiomer shows
much greater pharmacological activity than the (R)-MDPV
[23, 24]
Figure 2 shows the representative chiral CE electrophero-
grams on the separation of racemic MDPV using 6-Me--CD
at two different concentrations. It is demonstrated, that enan-
tioselectivity occurred in a reasonable concentration range, as
2.5 mM selector concentration resulted in the baseline sepa-
ration of the enantiomers in less than 4 minutes, providing
rather symmetric peak shapes without any additional opti-
mization. These data support that 6-Me--CD can enter into
the CD-based chiral selector market as a new single isomer
entity.
3.3 Structural characterization of the host-guest
system by NMR
In order to characterize the host-guest interactions at the
molecular level and to get a deeper insight into the molec-
ular interactions between the 6-Me--CD and the MDPV
enantiomers 1H and 2D ROESY NMR experiments were
performed according to previous works [25, 26]. The enan-
tioselectivity of 6-Me--CD was monitored at neutral pH,
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Figure 5. Proposed geometric arrangement ofMDPV in the cavity
of 6-Me--CD, based on the ROESY experiment.
with racemicMDPV. In the 1HNMR spectrumof the racemic
guest and the 6-Me--CD host, complexation induced chemi-
cal shift changes could be observed for the H-2, H-4, H-5 and
H-6 resonances of MDPV (see Fig. 3).
2D ROESY NMR spectrum was acquired in order to con-
firm the hypothesized substantial interactions between 6-Me-
-CD and MDPV at the atomic level. A partial ROESY spec-
trum of the MDPV/6-Me-CD system is shown in Fig. 4.
Intense cross-peaks can be observed between the aro-
matic moiety of MDPV and the inner cavity protons of 6-Me-
-CD, suggesting that the phenyl moiety is fully immersed
into the cavity. As the resonances of the methylenedioxy moi-
ety show intense cross-peaks exclusively with CD protonsH7,
H6 and H5, an inclusion arrangement in which the phenyl
ring is located in the “extended cavity” surrounded by the
methoxy groups at the primary side of the CD can be hy-
pothesized. This geometrical arrangement can be supported
by nonpolar interactions between the methylenedioxy moi-
ety of MPDV and the nonpolar methoxy groups of the host.
The inclusion complex of MDPV is schematically shown in
Fig. 5, using key ROESY interactions for the determination of
MDPV orientation in the cavity. This arrangement may also
be favoured by the polar interactions between the positively
charged tertiary amine and the secondary OH groups of the
host.
4 Concluding remarks
Heptakis(6-O-methyl)--CD has been effectively prepared
through a five-step synthetic strategy. Each intermediate has
been isolated in high purity without the need of chromatogra-
phy and thoroughly characterized. The methylated single iso-
mer CD acts as a promising chiral selector in CE and can sep-
arate the two enantiomers of the drugMDPV. A 2Dmodel for
the host-guest spatial interactions has been proposed based
on the extensive NMR characterization. Additionally, the de-
veloped synthetic approach is versatile, amenable of scale-up
and applicable to any per-6-substituted CD. The preparation
of primary-side alkylated CDs adds a powerful tool to the ana-
lytical separation of chiral drugs, furthermore industrial pro-
duction of these selectors might open new avenues towards
preparative-scale resolution of a large variety of enantiomers.
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